Literature DB >> 25262713

Predictors of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.

Natsuko Kawada1, Hiroyuki Uehara, Shigenori Nagata, Mutsumi Tsuchishima, Mikihiro Tsutsumi, Yasuhiko Tomita.   

Abstract

OBJECTIVE: Indication of surgery for branch duct intraductal papillary mucinous neoplasm (BD-IPMN) proposed by the consensus guidelines revised in 2012 was too complex to refer to in clinical practice. This study aimed to identify simple predictors of malignancy in BD-IPMN.
METHODS: Consecutive 202 patients with BD-IPMNs were enrolled. They comprised 35 patients that underwent surgery and 167 that were followed up without surgery by being regarded as benign neoplasms. Cutoff values of cyst size, main pancreatic duct (MPD) diameter, and mural nodule size were determined by receiver operator characteristic (ROC) curve. Factors that may discriminate benign from malignant BD-IPMNs were analyzed by multivariate logistic regression model.
RESULTS: Cutoff values of cyst size, MPD diameter, and mural nodule size were determined to be 30 mm, 6 mm, and 10 mm, respectively. Multivariate analysis demonstrated that mural nodule ≥10 mm (OR 198, 95% CI 23.1-1690, P<0.0001) and positive cytology (OR 634, 95% CI 49.1-8,190, P<0.0001) were predictors of malignancy in BD-IPMN. When BD-IPMNs with mural nodules ≥10 mm or positive cytology were diagnosed as malignant, sensitivity, specificity, and overall accuracy were 88%, 98%, and 97%, respectively.
CONCLUSIONS: Mural nodule ≥10 mm and positive cytology were demonstrated to be simple predictors of malignancy in BD-IPMN.

Entities:  

Year:  2014        PMID: 25262713     DOI: 10.6092/1590-8577/2805

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  7 in total

Review 1.  Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk.

Authors:  Annabelle L Fonseca; Kimberly Kirkwood; Michael P Kim; Anirban Maitra; Eugene J Koay
Journal:  Pancreas       Date:  2018-03       Impact factor: 3.327

Review 2.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

3.  Precancerous Lesions and Carcinoma of the Pancreas.

Authors:  Markus W Büchler; Irene Esposito; Lars Grenacher; Thilo Hackert; Julia Mayerle
Journal:  Viszeralmedizin       Date:  2015-02-03

4.  Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.

Authors:  Tae-Hyeon Kim; Young-Sik Woo; Hyung-Ku Chon; Jin-Hyeok Hwang; Kyo-Sang Yoo; Woo-Jin Lee; Kwang-Hyuck Lee; Jong-Kyun Lee; Seok-Ho Dong; Chang-Hwan Park; Eun-Taek Park; Jong-Ho Moon; Ho-Gak Kim; Kwang-Bum Cho; Hong-Ja Kim; Seung-Ok Lee; Young-Koog Cheon; Jeong-Mi Lee; Jin-Woo Park; Myung-Hwan Kim
Journal:  Gut Liver       Date:  2018-09-15       Impact factor: 4.519

Review 5.  Cyst Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Pathology.

Authors:  Lars Grenacher; Albert Strauß; Frank Bergmann; Matthew Birdsey; Julia Mayerle
Journal:  Viszeralmedizin       Date:  2015-02

6.  A large mural nodule in branch duct intraductal papillary mucinous adenoma of the pancreas: a case report.

Authors:  Koichiro Haruki; Shigeki Wakiyama; Yasuro Futagawa; Hiroaki Shiba; Takeyuki Misawa; Katsuhiko Yanaga
Journal:  Surg Case Rep       Date:  2015-02-24

Review 7.  Predictive performance of factors associated with malignancy in intraductal papillary mucinous neoplasia of the pancreas.

Authors:  M Heckler; L Brieger; U Heger; T Pausch; C Tjaden; J Kaiser; M Tanaka; T Hackert; C W Michalski
Journal:  BJS Open       Date:  2018-02-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.